Workshop Date and Time
Friday, June 14, 2019, 1:30 – 2:30 pm, Eastern Time Register Now
Registrants can listen in live over the phone or online as a webcast.
- Overview of Acute Myelogenous Leukemia (AML)
- Current Treatment Approaches
- Transplantation as a Treatment Option for AML
- New Therapies
- The Role of Clinical Trials: How They Increase Your Treatment Options
- Clinical Trial Updates
- Symptom, Side Effect & Pain Management Tips
- Key Questions to Ask Your Health Care Team
- Quality-of-Life Concerns
- Questions for Our Panel of Experts
Our Panel of Experts
Mary-Elizabeth Percival, MD, MS
Assistant Professor of Medicine (Hematology), University of Washington, Assistant Member (Clinical Research Division), Fred Hutchinson Cancer Research Center, Attending Physician, Seattle Cancer Care Alliance
Eytan M. Stein, MD
Hematologic Oncologist, Clinical Trialist, Acute Myeloid Leukemia, Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center
Carolyn Messner, DSW, OSW-C, FAPOS, FAOSW
Director of Education and Training, CancerCare
Continuing Education Credits
Social Workers: This program has been submitted to the University of Texas MD Anderson Cancer Center, an approved provider through the Texas State Board of Social Work Examiners, provider #CS4607, for 1.0 Contact Hour.
Cancer Care, Inc. is recognized by the New York State Education Department’s State Board for Social Work as an approved provider of continuing education for licensed social workers #SW-0088. This workshop is approved for 1.0 Contact Hour.
Registered Dietitians: This program has been submitted to the Commission on Dietetic Registration for one Continuing Professional Education Unit (CPEU).
To request continuing education paperwork, please email your name, profession, and address to email@example.com after the program. All paperwork for continuing education credit must be requested, completed, and submitted within two weeks of the live program.
You can download the brochure for this workshop(80.4 KB)